Continuous Glucose Monitors for Non Diabetics: What the Evidence Shows
Over-the-counter glucose monitors are now a $340 million annual market among people without diabetes, but the evidence they improve health outcomes in that group is thinner than the marketing suggests.
By Eli Okafor, Health & Wellness
· 2 min read
Key Takeaways
- •The US market for OTC glucose monitors among non-diabetics reached an estimated $340 million in 2025, up 209 percent from 2022.
- •The devices are well validated for diagnosed diabetes but lack large randomized trials proving benefit for non-diabetics.
- •A small 2024 Stanford study found a modest 1.2 kilogram weight loss difference among monitor wearers, but called for a larger replication study.
- •Normal, healthy people experience glucose fluctuations that are not meaningful in the same way they are for diagnosed diabetics.
Sales of over-the-counter continuous glucose monitors to people without diabetes reached an estimated $340 million in the United States in 2025, up from $110 million in 2022, according to market research firm Grand View Insight, even though the devices were originally developed and clinically validated for managing diagnosed diabetes.
The pitch to non-diabetics is usually framed around energy levels, weight management, or general metabolic health. Here is what the actual research supports and what it does not.
What is actually known versus what is still being studied
The Short Answer
In people with diabetes, continuous glucose monitors are well established to improve blood sugar control and reduce dangerous low-blood-sugar events. In people without diabetes, there is currently no large randomized trial showing that wearing one improves weight, energy, or long-term health outcomes, though several small studies are underway.
A small 2024 study at Stanford, following 109 non-diabetic adults for 10 weeks, found that participants who wore a glucose monitor lost an average of 1.2 kilograms more than a control group given standard dietary advice without the device, a modest difference that the study's own authors described as requiring replication in a larger sample before drawing firm conclusions.
$340 million
estimated 2025 US market for over-the-counter glucose monitors among non-diabetics
Up from $110 million in 2022, a 209 percent increase over three years, according to Grand View Insight.
Blood sugar spikes and dips are normal in people without diabetes and generally self-correct without intervention. The clinical thresholds that define a concerning glucose reading, used to guide treatment in diagnosed diabetics, have not been validated as meaningful targets for people with normal metabolic function.
“We have a device that is genuinely excellent at doing one job, helping a diabetic manage a serious medical condition, and it is being marketed for a second job we do not yet have the evidence to support.”
Bottom line
Solid evidence: continuous glucose monitors reliably help people with diagnosed diabetes manage their condition, with decades of clinical research behind that use case. Still being studied: whether wearing one provides a meaningful health benefit to someone without diabetes, beyond the general awareness that comes from paying closer attention to diet, which a food journal can also provide at a fraction of the cost.
If you do not have diabetes or prediabetes and you are considering a glucose monitor, it is reasonable to view it the way you would any new wellness gadget: potentially useful for building awareness of your own habits, but not yet backed by evidence that it changes health outcomes on its own. Talk to an actual physician before making decisions based on the readings, since normal glucose fluctuation can look alarming to an untrained reader.
- wearable health tech
- nutrition
- diabetes
- medical evidence
Sources
- 01Continuous Glucose Monitor Market Report 2025, Grand View Insightexample.com
- 02Glucose Monitoring and Weight Outcomes in Non-Diabetic Adults, Pilot Study, Stanford University School of Medicineexample.com
Corrections
No corrections have been made to this article.
About the reporter
Health & Wellness Reporter, Trestlewire
I come from a health-policy and medical-reporting background. I want to be clear about one thing up front: I am not a physician, and nothing I write is medical advice. My job is to report on health accurately, not to practice it.
Read full bio and all stories →